LYONDELL CHEMICAL CO 4

Accession 0001181431-05-035010

CIK 0000842635operating

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 2:56 PM ET

Size

54.6 KB

Accession

0001181431-05-035010

Insider Transaction Report

Form 4

Period: 2005-06-14

LYONDELL CHEMICAL COLYO

GELB MORRIS

Executive Vice President & COO

Transactions

Sale
Common Stock
2005-06-15$25.10/sh−15,000$376,500→ 118,886 total
Exercise/Conversion
Common Stock
2005-06-15$14.63/sh+40,000$585,200→ 158,886 total
Sale
Common Stock
2005-06-15$25.00/sh−128,120$3,203,000→ 118,886 total
Sale
Common Stock
2005-06-15$25.12/sh−40,000$1,004,800→ 118,886 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$14.63/sh−16,000$234,080→ 59,000 total
Exercise: $14.63Exp: 2012-05-01→ Common Stock (16,000 underlying)
Exercise/Conversion
Common Stock
2005-06-15$14.63/sh+15,000$219,450→ 133,886 total
Exercise/Conversion
Common Stock
2005-06-14$12.91/sh+106,050$1,369,371→ 224,936 total
Exercise/Conversion
Common Stock
2005-06-15$14.63/sh+6,710$98,167→ 125,596 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$13.80/sh−101,680$1,403,184→ 68,290 total
Exercise: $13.80Exp: 2012-02-08→ Common Stock (101,680 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$13.80/sh−68,290$942,402→ 0 total
Exercise: $13.80Exp: 2012-02-08→ Common Stock (68,290 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$16.25/sh−128,120$2,081,950→ 0 total
Exercise: $16.25Exp: 2011-02-01→ Common Stock (128,120 underlying)
Exercise/Conversion
Common Stock
2005-06-14$16.25/sh+39,702$645,158→ 158,588 total
Exercise/Conversion
Common Stock
2005-06-15$16.25/sh+128,120$2,081,950→ 247,006 total
Sale
Common Stock
2005-06-15$25.00/sh−101,680$2,542,000→ 118,886 total
Exercise/Conversion
Common Stock
2005-06-15$13.80/sh+101,680$1,403,184→ 220,566 total
Exercise/Conversion
Common Stock
2005-06-15$14.63/sh+16,000$234,080→ 134,886 total
Exercise/Conversion
Common Stock
2005-06-15$14.63/sh+4,000$58,520→ 122,886 total
Sale
Common Stock
2005-06-14$25.00/sh−106,050$2,651,250→ 118,886 total
Exercise/Conversion
Common Stock
2005-06-15$13.80/sh+68,290$942,402→ 187,176 total
Sale
Common Stock
2005-06-15$25.10/sh−16,000$401,600→ 118,886 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$14.63/sh−4,000$58,520→ 0 total
Exercise: $14.63Exp: 2012-05-01→ Common Stock (4,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-14$16.25/sh−39,702$645,158→ 128,120 total
Exercise: $16.25Exp: 2011-02-01→ Common Stock (39,702 underlying)
Sale
Common Stock
2005-06-14$25.00/sh−39,702$992,550→ 118,886 total
Sale
Common Stock
2005-06-15$25.05/sh−6,710$168,086→ 118,886 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$14.63/sh−6,710$98,167→ 75,000 total
Exercise: $14.63Exp: 2012-05-01→ Common Stock (6,710 underlying)
Sale
Common Stock
2005-06-15$25.05/sh−68,290$1,710,665→ 118,886 total
Sale
Common Stock
2005-06-15$25.15/sh−4,000$100,600→ 118,886 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-14$12.91/sh−106,050$1,369,371→ 0 total
Exercise: $12.91Exp: 2010-02-03→ Common Stock (106,050 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$14.63/sh−15,000$219,450→ 44,000 total
Exercise: $14.63Exp: 2012-05-01→ Common Stock (15,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2005-06-15$14.63/sh−40,000$585,200→ 4,000 total
Exercise: $14.63Exp: 2012-05-01→ Common Stock (40,000 underlying)

Holdings

Common Stock
(indirect: By 401(k))
13,562

Footnotes (6)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2005.
[F2]Includes shares accumulated in the Company's Dividend Reinvestment Plan.
[F3]The total award vested annually in 1/3 increments on February 3, 2001, 2002, and 2003.
[F4]The total award vested annually in 1/3 increments on February 1, 2002, 2003, and 2004.
[F5]1/3 of the award vested on February 8, 2003, 1/3 of the award vested on February 8, 2004 and 1/3 of the award vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc.
[F6]1/3 of the award vested on May 1, 2003, 1/3 of the award vested on May 1, 2004 and 1/3 of the award vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc.

Documents

1 file

4
rrd82787.xmlPrimary

Issuer

LYONDELL CHEMICAL CO

CIK 0000842635

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000842635

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 2:56 PM ET
Size: 54.6 KB

View on SEC.gov